Quanome Technologies, Inc. — Form 10-K
Filed September 25, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 8/100
What the filing says
This 10-K filing contains exhibits disclosing Quanome's corporate governance framework: (1) a form indemnification agreement for directors/officers protecting them from liability during service and post-termination; (2) a standard employment agreement template for executives covering compensation, termination, confidentiality, and non-compete provisions; and (3) a list of wholly-owned subsidiaries including entities in the Cayman Islands, Delaware, and People's Republic of China (Smart Reserve entities, XDT entities, and Hupan Pharmaceutical). No material transactions, changes, or new counterparties are disclosed—these are boilerplate governance documents and structural disclosures.
Why this rating
Routine corporate governance exhibits with no material business event. Disclosure of subsidiary structure is standard. No financial impact or strategic change.
See more from September 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.